Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Healthcare Industry News Cadence wants to make chronic care proactive. Memorial Hermann is now testing that thesis Chronic care is moving beyond clinic walls. Memorial Hermann’s Cadence deal tests whether AI-enabled home monitoring can reduce care gaps. bySrinathApril 30, 2026